Skip to content

Media Release, February 14, 2011


President Would Increase FDA’s Budget Authority (BA) Appropriation by $382 million for FY 12

WASHINGTON, D.C., February 14, 2011 — The Alliance for a Stronger FDA today applauded President Obama’s FY 12 budget request for the US Food and Drug Administration. The FDA’s budget of $2.365 billion would be increased to $2.747 billion, about a $382 million increase.

“The President has demonstrated his understanding of FDA’s critical mission, particularly in the food safety area, and has proposed funding consistent with the demands being placed on the agency,” said Nancy Bradish Myers, President of the Alliance for a Stronger FDA and President of Catalyst Healthcare Consulting. “The President has underscored his commitment to deficit reduction, but wisely sees FDA as a necessary exception.”

The President’s budget request proposes increases of about $170 million for food programs and $80 million for medical product programs. Other large increases support programs in the Commissioner’s office, such as increasing FDA’s scientific base, and monies for increased rental costs.

“FDA funding should reflect that the agency’s responsibilities and workload increase each year–through globalization, scientific complexity, and the growth of industry, as well as through new mandates,” said Margaret Anderson, Vice President of the Alliance and Executive Director of FasterCures. “We want to be sure that the President and Congress have a clear picture of how FDA contributes to economic growth and national security, as well as protecting our public health.”

Ms. Myers added:  “Today’s investment of 2 cents per American per day is small compared to the benefits of a strong FDA and the risks from an underfunded FDA. We look forward to working further with the President and Congress to be sure that the needs of the American people are being met.”

The Alliance’s 180 (and growing) membership is comprised of consumer, patient, professional and research groups, companies, trade associations, and individuals who support increased appropriated funding for FDA.  The Alliance is the only multi-stakeholder group that advocates for increasing resources at FDA to match the agency’s responsibilities.

More information about the Alliance can be found at

A chart is also available that compares the President’s FY 12 budget request with FY 10 (which is also the level of the current FY 11 CR) and the House of Representative’s proposed FY 11 CR (to be debated on the House floor this week). Bullets at the bottom of the chart also provide information about user fees and other fees collected by FDA.